Remidio Innovative Solutions

Remidio's core business revolves around designing and manufacturing portable, easy-to-use ophthalmic devices integrated with artificial intelligence and telemedicine capabilities. The company's flagship product is the Fundus on Phone (FOP), a smartphone-based non-mydriatic fundus camera that captures high-quality retinal images without requiring pupil dilation. This device empowers a wide range of users, from ophthalmologists and primary care physicians to minimally trained healthcare workers and volunteers, to conduct retinal exams in diverse settings, including clinics, emergency rooms, and remote rural centers. The business model involves the sale of these hardware devices, which are often bundled with their cloud-based platform, Remidio Connect, for data management and telehealth consultations.

The company’s product suite is distinguished by its integration of offline AI algorithms. The Medios AI platform can analyze retinal images on the device to detect indicators of various eye diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration (AMD) in seconds, without needing an internet connection. This is a critical feature for deployments in areas with poor connectivity. The AI provides heat maps and clinical-grade reports to aid in early detection and timely referrals. Remidio has received regulatory approvals for its devices and AI, including FDA 510(k) in the US and CDSCO in India, and has impacted millions of patients across more than 40 countries.